- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Glipizide and Glargine
Total 272055 results
-
SanofiCompleted
-
Mylan Inc.Mylan GmbHCompletedType 2 DiabetesUnited States, Jordan, Korea, Republic of, Slovakia, South Africa, Taiwan
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 1 | Healthy VolunteersUnited States
-
SanofiCompletedDiabetes Mellitus, Type 2United States
-
Emory UniversityMerck Sharp & Dohme LLC; University of Michigan; Temple University; Ohio UniversityCompleted
-
Massachusetts General HospitalBrigham and Women's Hospital; Joslin Diabetes Center; Broad InstituteActive, not recruitingDiabetes Mellitus, Type 2United States
-
Vanderbilt University Medical CenterSanofiCompleted
-
SanofiCompletedType 2 Diabetes MellitusUnited States, South Africa, Canada, Czechia, Estonia, Finland, France, Germany, Hungary, Latvia, Mexico, Netherlands, Romania
-
SanofiCompletedType 2 Diabetes MellitusUnited States, Finland, South Africa, Canada, Mexico, Chile, Spain, Russian Federation, France, Germany, Hungary, Portugal, Romania
-
SanofiCompletedType 2 Diabetes MellitusUnited States, Bulgaria, Canada, Czech Republic, Denmark, Estonia, Finland, Hungary, Japan, Latvia, Lithuania, Netherlands, Puerto Rico, Romania, Slovakia, Sweden
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Healthy VolunteersGermany
-
SanofiCompletedDiabetes Mellitus, Type 2France
-
Xijing HospitalUnknown
-
Novo Nordisk A/SCompletedHealthy | Diabetes Mellitus, Type 2 | DiabetesGermany
-
SanofiCompletedType 2 DiabetesFrance
-
Skane University HospitalMedical Research Council; Skane County Council Research & Development FoundationCompletedType 2 Diabetes | Secondary Drug FailureSweden
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Puerto Rico
-
SanofiCompletedType I Diabetes MellitusBrazil
-
Shenzhen Second People's HospitalUnknown
-
Novo Nordisk A/SCompleted
-
GlaxoSmithKlineCompletedAtherosclerosisUnited States, Russian Federation, Spain, Germany, Korea, Republic of, Sweden, Canada, Netherlands, Thailand, Hong Kong, Argentina, France, Mexico, Greece, Poland, Italy, India, Brazil, Latvia, Czech Republic
-
Merck Sharp & Dohme LLCCompleted
-
SanofiCompletedType 2 Diabetes MellitusUnited States, Australia, Spain, Korea, Republic of, Hungary, Mexico, Italy, Poland, Argentina, Canada, Colombia, France, Germany, Japan, Peru, Romania, Sweden, United Kingdom
-
Gan and Lee Pharmaceuticals, USACompletedDiabetes Mellitus, Type 1United States
-
Mira ZuidgeestSanofi; Innovative Medicines Initiative; IMI Trials@Home consortiumRecruitingDiabetes Mellitus, Type 2United Kingdom, Denmark, Germany
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusChina, Mexico, Korea, Republic of, Russian Federation
-
SanofiCompletedType 2 Diabetes MellitusUnited States
-
SanofiActive, not recruiting
-
SanofiCompleted
-
Emory UniversityNovo Nordisk A/SCompleted
-
University of AarhusCompletedDiabetes Mellitus, Type 1Denmark
-
BiodelCompletedDiabetes MellitusUnited States
-
Medical University of ViennaCompletedType 2 Diabetes MellitusAustria
-
SanofiCompleted
-
University of PadovaCompletedCardiovascular Disease | Type 2 Diabetes | Endothelial DysfunctionItaly
-
Munich Municipal HospitalAventis PharmaceuticalsUnknownCoronary Artery Disease | Type 2 DiabetesGermany
-
SanofiCompleted
-
Medical University of GrazCompletedDiabetes Mellitus, Type 2Austria
-
Gan and Lee Pharmaceuticals, USACompletedDiabetes Mellitus, Type 1Spain, United States, Germany, Czechia, Hungary, Poland
-
SanofiCompletedDiabetesPeru, Ukraine, Colombia, Egypt, India, Indonesia, Israel, Jordan, Kuwait, Lebanon, Mexico, Philippines, Russian Federation, Saudi Arabia, Singapore, Taiwan, Thailand, United Arab Emirates
-
Emory UniversityCompletedPoor Glycemic ControlUnited States
-
SanofiCompleted
-
SanofiCompleted
-
SanofiCompletedType 1 Diabetes MellitusFrance, Czechia, Chile, Israel, Spain, Hungary, Mexico, Serbia, Japan, Canada, Brazil, Sweden, Denmark, Argentina, United States, Bulgaria, Germany, Italy, Latvia, North Macedonia, Poland, Romania, Russian Federation, United Kingdom
-
Merck Sharp & Dohme LLCCompletedDiabetes Mellitus, Type 2 | Renal Insufficiency, Chronic
-
SanofiCompletedType 2 Diabetes MellitusGermany, United Kingdom
-
SanofiCompleted
-
SanofiTerminated